Oxford Biotherapeuticsobtis A Clinical Stage Oncology Company Dedicated To Developing Innovative Cancer Therapiesthe Company Focuses On First In Class Treatments Using Targeted Approaches Such As Antibody Drug Conjugatesadcs T Cell Engagerstces Immuno Oncologyio Radiopharmaceuticalsand Bispecific Therapeuticsobt S Proprietary Ogapaverify Platform Plays A Crucial Role In Identifying Novel Cancer Specific Membrane Protein Targetsenhancing The Discovery Of New Therapies With Over 30 Clinical Stage Assets And More Than 90 Partnered Programsobt Emphasizes Scientific Excellence And Strategic Partnerships To Expand Treatment Options For Patientsthe Company Operates R&D Sites In The Uk And The Ussupported By A Team Of Over 50 Employeesobt Has Established More Than 60 Partnershipsincluding A Collaboration With Roche Aimed At Discovering New Targets For Antibody Based Cancer Therapiesthe Company Is Committed To Addressing Unmet Medical Needs In Oncology And Advancing The Development Of Next Generation Cancer Treatments
No conferences found for this company.
| Company Name | Oxford Biotherapeutics Ltd |
| Country |
United Kingdom
|
| Address | N/A |
| Telephone | N/A |
| N/A |
